How much revenue did Ardelyx generate this year?
Ardelyx has achieved a revenue of 213.49 M USD this year.
Ardelyx Revenue 2024
Ardelyx Revenue
213.49 M USD
Ardelyx Dividend yield
Ticker
ARDX
ISIN
US0396971071
WKN
A116X0
In 2024, Ardelyx's sales reached 213.49 M USD, a 71.54% difference from the 124.46 M USD sales recorded in the previous year.
The Ardelyx Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2029e | 1.08 | 9,86 |
| 2028e | 0.95 | 11,26 |
| 2027e | 0.77 | 13,78 |
| 2026e | 0.57 | 18,57 |
| 2025e | 0.37 | 28,85 |
| 2024e | 0.21 | 49,96 |
| 2023 | 0.12 | 85,70 |
| 2022 | 0.05 | 92,10 |
| 2021 | 0.01 | 90,10 |
| 2020 | 0.01 | 98,15 |
| 2019 | 0.01 | 88,64 |
| 2018 | 0 | 81,99 |
| 2017 | 0.04 | 80,00 |
| 2016 | - | - |
| 2015 | 0.02 | 443,87 |
| 2014 | 0.03 | 337,32 |
| 2013 | 0.03 | 368,69 |
| 2012 | 0.01 | 1971,55 |
Ardelyx Aktienanalyse
What does Ardelyx do?
Ardelyx Inc. is a biotechnology company founded in 2007 by researchers to develop life-changing medications. The company is based in Fremont, California, USA and focuses on researching kidney and gastrointestinal diseases, as well as cardiology and metabolic disorders. Its business model is based on identifying unmet medical needs and developing drugs to meet those needs. Ardelyx works closely with patients to understand their medical problems and develop specific solutions. The company categorizes its products into three categories: kidney, gastrointestinal, and cardiology/metabolism. Ardelyx has developed a medication called Tenapanor for chronic kidney disease, which reduces phosphorus levels in the blood, lowering the risk of cardiovascular disease. For gastrointestinal diseases like irritable bowel syndrome and ulcerative colitis, Ardelyx has developed Tenapanor to reduce pain and discomfort by regulating fluid and nutrient volumes in the intestine. In the field of cardiology/metabolic disorders, Ardelyx is working on developing medications to regulate cholesterol levels and the lipid metabolism system, which can be the cause of heart disease or diabetes. The company is awaiting approval for Ibsrela, a medication for chronic constipation and pelvic floor disorders, as well as RDX013, a medication to regulate lipid metabolism. Ardelyx also benefits from collaborating with other pharmaceutical companies, such as AstraZeneca, which has supported the development of novel treatments for kidney diseases. The partnership with AstraZeneca focuses on creating treatments that prevent damage to kidney cells or the cardiovascular system. Ardelyx has also received a number of awards and recognition, demonstrating its effectiveness and performance in the biotechnology industry. For example, in 2019, Inc. Magazine included Ardelyx for the fourth consecutive year in its list of the "5000 fastest-growing private companies in the USA." This publication highlighted Ardelyx's tripling of its employee count during the same period. Overall, Ardelyx focuses on researching and developing innovative medications that meet the needs of patients with kidney, gastrointestinal, cardiology, and metabolic disorders. Despite being a young company, it already produces a range of innovative products and is committed to developing life-changing medications through its research and improving the quality of life for affected patients. Output: Ardelyx Inc. is a biotechnology company focused on developing life-changing medications for kidney, gastrointestinal, cardiology, and metabolic disorders. They collaborate with patients to understand their medical problems and develop specific solutions. They have developed medications such as Tenapanor for chronic kidney disease and gastrointestinal diseases. They are awaiting approval for medications to treat chronic constipation and pelvic floor disorders, as well as regulate lipid metabolism. Ardelyx has partnerships with other pharmaceutical companies like AstraZeneca. They have received awards for their effectiveness and performance in the biotechnology industry. Ardelyx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Ardelyx's Sales Figures
The sales figures of Ardelyx originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Ardelyx’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Ardelyx's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Ardelyx’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Ardelyx Stock
How much was the turnover of the company Ardelyx compared to the previous year?
The revenue of Ardelyx has increased by 71.54% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Ardelyx?
The revenue of Ardelyx is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Ardelyx measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Ardelyx so important for investors?
The revenue of Ardelyx is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Ardelyx pay?
Over the past 12 months, Ardelyx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ardelyx is expected to pay a dividend of 0 USD.
What is the dividend yield of Ardelyx?
The current dividend yield of Ardelyx is .
When does Ardelyx pay dividends?
Ardelyx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ardelyx?
Ardelyx paid dividends every year for the past 0 years.
What is the dividend of Ardelyx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ardelyx located?
Ardelyx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ardelyx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ardelyx from 5/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.
When did Ardelyx pay the last dividend?
The last dividend was paid out on 5/20/2024.
What was the dividend of Ardelyx in the year 2023?
In the year 2023, Ardelyx distributed 0 USD as dividends.
In which currency does Ardelyx pay out the dividend?
The dividends of Ardelyx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Ardelyx stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Ardelyx
Our stock analysis for Ardelyx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ardelyx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
